A combination therapy that adds a recently approved drug to the current standard of care for newly diagnosed acute myeloid ...

Here's why. How does measles spread? According to the Centers for Disease Control and Prevention's ...

Revumenib was generally well-tolerated in combination with venetoclax/azacitidine in older, newly diagnosed mNPM1 and KMT2Ar AML patients – – Promising clinical activity and deep responses observed ...

Robust responses observed across subgroups, regardless of co-mutations, number of prior lines of therapy, or prior venetoclax, within efficacy-evaluable pivotal R/R mNPM1 AML population – – 60% (3/5) ...

Understanding these warning signs and recognizing when seemingly unrelated symptoms ... Modern AML treatment typically involves intensive chemotherapy designed to eliminate leukemia cells and ...

She learned she had acute myeloid leukemia, an aggressive blood cancer ... At a follow-up appointment in October 2024, she shared her new symptoms. “I told them that the headaches are ...